- Home
- Automated
- List of product information
- OFCIN FILM COATED TABLET 200 MG [SIN10119P]
OFCIN FILM COATED TABLET 200 MG [SIN10119P]
Active ingredients: OFCIN FILM COATED TABLET 200 MG
Product Info
OFCIN FILM COATED TABLET 200 MG
[SIN10119P]
Product information
Active Ingredient and Strength | OFLOXACIN - 200 MG |
Dosage Form | TABLET, FILM COATED |
Manufacturer and Country | YUNG SHIN PHARMACEUTICAL IND CO LTD - TAIWAN |
Registration Number | SIN10119P |
Licence Holder | YUNG SHIN PHARMACEUTICAL (SINGAPORE) PTE LTD |
Forensic Classification | PRESCRIPTION ONLY MEDICINES |
Anatomical Therapeutic Chemical (ATC) code | J01MA01 |
Indication(s):
For the treatment of infections caused by susceptible strains of microorganism in infections of the urinary tract, lower respiratory tract, skin and soft tissue, gonorrhoea and non-gonococcal urethritis and cervicitis.
Dosage and Administration:
Urinary tract infections: 200 to 400mg daily, preferably in the morning, increased if necessary in upper urinary tract infections to 400mg twice daily.
Lower respiratory tract infections: 400mg daily, preferably in the morning, increased if necessary to 400mg twice daily.
Skin and soft tissue infections: 200 to 400mg twice daily.
Uncomplicated gonorrhoea: 400mg as a single dose.
Non-gonococcal urethritis and cervicitis: 400mg daily in single or divided doses.
Renal impairment: When creatinine clearance is 20–50mL/minute, the dosage should be reduced by half (100–200mg). If creatinine clearance is less than 20mL/minute, 100mg should be given every 24 hours. In patients undergoing haemodialysis or peritoneal dialysis, 100mg should be given every 24 hours.
Liver impairment: Dose of ofloxacin should be reduced accordingly in patients with impaired liver function.
Contraindication(s):
Patient who has shown previous hypersensitivity to this drug or to other quinolone antibiotics.
Ofloxacin is contraindicated in patients with a history of epilepsy or with a lowered seizure threshold.
Ofloxacin is contraindicated in children or growing adolescents and in pregnant or breast-feeding women.
